|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 47/68 | (2017.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| C07K 14/71 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 3490582 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17835212.6 |
| Date of filing the European patent application | 2017-07-26 | |
| (97) | Date of publication of the European application | 2019-06-05 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-12 |
| (46) | Date of publication of the claims translation | 2024-07-25 |
| (86) | Number | PCT/US2017/043967 |
| Date | 2017-07-26 |
| (87) | Number | WO 2018/022762 |
| Date | 2018-02-01 |
| (30) | Number | Date | Country code |
| 201662367289 P | 2016-07-27 | US |
| (72) |
KUMAR, Ravindra , US
VENKATA SAI RAJASEKHAR SURAGANI, Naga , US
|
| (73) |
Acceleron Pharma Inc. ,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos, skirtos naudoti gydant mielofibrozę |
| COMPOSITIONS FOR USE IN TREATING MYELOFIBROSIS |
| Payment date | Validity (years) | Amount | |
| 2025-06-16 | 9 | 208.00 EUR |
| 2026-07-26 |